MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Identification of Rigidity in Parkinson’s Disease Using Wearable Technology

    P. Sharma, C. Sotirakis, J. Huxley, J. Fitzgerald, C. Antoniades (Oxford, United Kingdom)

    Objective: To evaluate the capacity of upper limb kinematic measures, collected using wearable technology, in (a) capturing clinical rigidity in Parkinson’s disease (PD) and (b)…
  • 2025 International Congress

    Virtual Reality to Assess for Digital Biomarkers of Visual Hallucinations in Parkinson’s Disease

    K. Getchell, S. Hirczy, A. Lin (Seattle, USA)

    Objective: Use a novel virtual reality (VR) protocol to evaluate for potential digital biomarkers of visual hallucinations (VH) in Parkinson’s Disease (PD). Background: VH are common…
  • 2025 International Congress

    Characterization of neuronal exosomes purified from plasma of Parkinson’s Disease Chilean patients

    V. Urbina, C. Aguilera, E. Larraechea, D. Sepulveda, R. Vidal (Santiago, Chile)

    Objective: The diagnosis of PD is usually late and has only palliative treatments that seek to slow the progression of motor symptoms. These characteristics make…
  • 2025 International Congress

    Sex Differences for Autopsy-Confirmed Prodromal Lewy Body Dementia

    F. Dino, L. Gunn-Sandell, A. Tsai, D. Carter, Y. Wang, E. Bayram (Aurora, USA)

    Objective: To assess sex differences in prodromal Lewy body dementia (LBD) compared to Alzheimer’s disease (AD) Background: Identifying LBD at the prodromal stage can provide…
  • 2025 International Congress

    Cognitive Biases in Movement Disorders: Implications for Clinical Decision-Making and Patient Perception of Symptoms

    N. Choudhury, D. Buonadonna, B. Carr (Gainesvile, USA)

    Objective: To explore how cognitive biases affect decision-making in patients with movement disorders, including misjudgments in symptom perception, risk-taking in treatment decisions and adherence to…
  • 2025 International Congress

    Modeling Dementia in Patients with Parkinson’s Disease Years After DBS

    S. Gunawardena, E. Assaedi, T. George, C. Sonneborn, D. Floden (Cleveland, USA)

    Objective: The objective of this study is to identify pre-operative cognitive characteristics of patients who are candidates for deep brain stimulation surgery that may contribute…
  • 2025 International Congress

    Caution in the creation of Parkinson’s disease cognitive composites

    D. Gonzalez, A. Karstens, J. Fleisher, S. Patel, C. Goetz (Chicago, USA)

    Objective: To evaluate the structural validity of new cognitive composites in Parkinson’s disease (PCCs). Background: PCCs created from constituent tasks are promising in their single-index…
  • 2025 International Congress

    The PDCogniCare Toolkit: Developing a harmonised neuropsychological toolkit specific to Parkinson’s Disease

    E. Mccann, D. Pourzinal, D. Sriram, L. Mitchell, J. Liddle, A. Lehn, N. Dissanayaka (Herston, Australia)

    Objective: To critically evaluate neuropsychological measures predictive of cognitive decline in Parkinson’s disease (PD) with the aim of proposing a comprehensive, evidence-based neuropsychological toolkit specific…
  • 2025 International Congress

    The Impact of Depression on Information Storage, Consolidation and Evocation Processes in a Group of Patients Diagnosed with Idiopathic Parkinson’s Disease without Dementia by Deep Brain Stimulation. Descriptive study of the ESDEPARK Scale.

    C. Alberto Hurtado-González, J. Felipe Ayala-Rico, S. Ospina-Otalvaro, P. Andrea Gutiérrez-Lenis, A. Lucumi Moreno, M. Cañas-Lucendo, D. Reyes-Torres, L. Villegas-Trujillo, S. Ordoñez-Cure, K. Alejandro Rivera-Quintero (Cali, Colombia)

    Objective: To identify the clinical correlation between neurocognitive functioning in memory and depressive symptomatology in patients with IPDWD, assessed by a new scale (ESDEPARK) that…
  • 2025 International Congress

    Quality of Life Impact on Adults with Parkinson’s Disease Experiencing Morning Akinesia: Real-World Observational Findings

    O. de Fabregues, K. Onuk, C. Yan, P. Kukreja, L. Bergmann, S. Colman, D. Falconer, J. Sarna, F. Ory-Magne, L. Defebvre, V. Fung (Barcelona, Spain)

    Objective: To compare the quality of life (QoL) in Parkinson’s Disease (PD) patients with and without morning akinesia (MA) in those using oral medications only…
  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 181
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley